BPG is committed to discovery and dissemination of knowledge
Review
Copyright: ©Author(s) 2026.
World J Gastroenterol. May 7, 2026; 32(17): 118502
Published online May 7, 2026. doi: 10.3748/wjg.v32.i17.118502
Table 1 Diagnostic applications of DNA methylation in gastrointestinal stromal tumors[70-72,74-78]
Ref.
Cohort/samples
Targets
Methodology
Key findings
Casey et al[71]59 GISTs (multi-institutional) + blood/salivaSDHC promoterBisulfite sequencingEpimutation found in approximately 94% of SDHx-WT cases, including Carney triad; mosaicism in peripheral tissues supports post-zygotic origin
Janeway et al[74]Pediatric and WT GIST (approximately 100)SDH subunits (SDHB, SDHC epimutations)IHC + genetic/epigenetic testingEstablished SDH-deficient GIST in children/WT adults; SDHB loss by IHC plus SDHC methylation testing defines subset
Haller et al[75]Carney triad GISTsSDHC promoterMethylation assaysRecurrent SDHC hypermethylation identified as defining event in Carney triad, absent in Carney-Stratakis
Angelini et al[76]63 tumors (KIT/PDGFRA-mutant vs SDH-deficient)Genome-wide450K arraysC promoter hypermethylation represents a characteristic alteration in Carney triad but is not detected in Carney-Stratakis
Killian et al[70]SDH-deficient vs syndromic GISTGenome-wide450K arraysSDH-deficient GISTs characterized by a hypermethylator profile, with succinate accumulation blocking TET enzyme activity
Miettinen et al[72]66/756 gastric GIST SDH-deficientSDH statusIHC + molecularDefined clinicopathologic spectrum of SDH-deficient GIST; IHC loss of SDHB as front-line marker
Saito et al[77]35 GISTsCpG island panel (p15, p16, p73, MGMT, hMLH1, MINT1/2/31)MSP94% tumors showed aberrant methylation; proposed CIMP-like category in GIST
Giger et al[78]Plasma/tissue paired samplesSEPT9 (plasma methylation)ddPCRCirculating methylated SEPT9 showed feasibility as a liquid biopsy biomarker (AUC: 0.74-0.79)


Write to the Help Desk